No results for ‘’
Fermenta Biotech Ltd
₹443.90
(2.60%)
Tue, 28 Jul 2026, 08:28 pm
Health Technology
Biotechnology
24.5KFermenta Biotech Price to Sales Ratio (P/S)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 32.33 | 5.82 | 6.22 | 4.23 | 4.98 | 3.51 | 5.21 | 26.88 | 14.81 | 294.61 | 0 | 17.46 | 19.43 | 6.43 | 10.31 | 15.87 | 38.41 | 0 | 0 | 10.38 |
| Price to book ratio | 1.05 | 0.70 | 0.56 | 0.31 | 0.66 | 0.77 | 0.90 | 0.88 | 0.88 | 1.04 | 1.23 | 1.22 | 5.26 | 3.01 | 1.98 | 2 | 1.59 | 0.98 | 1.51 | 2.20 |
| Price to sales ratio | 2.26 | 1.42 | 0.96 | 0.44 | 1 | 1.36 | 1.14 | 0.96 | 0.84 | 0.96 | 1.03 | 1.10 | 2.25 | 1.92 | 2.15 | 1.94 | 1.49 | 0.88 | 1.31 | 1.70 |
| Price to cash flow ratio | 3.72 | 7.95 | 4.33 | 3.20 | 28.04 | 0 | 3.30 | 6.33 | 9.04 | 12.91 | 0 | 0 | 14 | 10.36 | 33.16 | 14.48 | 20.37 | 3.14 | 4.75 | 24.57 |
| Enterprise value | 60.38Cr | 43.64Cr | 46.28Cr | 32.54Cr | 59.35Cr | 101Cr | 120Cr | 138Cr | 164Cr | 209Cr | 270Cr | 287Cr | 806Cr | 871Cr | 805Cr | 909Cr | 798Cr | 464Cr | 512Cr | 837Cr |
| Enterprise value to EBITDA ratio | 17.81 | 0 | 14.62 | 49.18 | 11.20 | 12.25 | 8.93 | 6.01 | 6.24 | 12.38 | 13 | 32.11 | 9.16 | 6.33 | 13.55 | 11.57 | 12.79 | 21.95 | 17.99 | 7.38 |
| Debt to equity ratio | 0.01 | 0.02 | 0.15 | 0.23 | 0.16 | 0.17 | 0.32 | 0.34 | 0.49 | 0.54 | 0.70 | 0.60 | 1.39 | 0.83 | 0.72 | 0.64 | 0.64 | 0.70 | 0.48 | 0.32 |
| Return on equity % | 0 | 12.75 | 9.31 | 7.45 | 13.86 | 25.03 | 18.18 | 3.24 | 6.06 | 0.35 | -0.87 | -8.33 | 25.08 | 62.64 | 21.97 | 13.58 | 4.22 | -14.86 | -7.64 | 23.59 |
Fermenta Biotech Ltd Price to Sales Ratio
The Fermenta Biotech Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Fermenta Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Fermenta Biotech Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Fermenta Biotech Ltd (NSE: , BSE: 506414) is currently trading at ₹443.90, with a market capitalization of ₹1269.95Cr. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Fermenta Biotech Ltd Price to Sales Ratio is essential for fundamental analysis.
Fermenta Biotech Ltd Price to Sales Ratio Current Value
The current Fermenta Biotech Ltd Price to Sales Ratio stands at 1.70.
The latest Fermenta Biotech Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Fermenta Biotech Ltd Price to Sales Ratio Historical Trend
The Fermenta Biotech Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 1.70
- 2023: 1.31
- 2022: 0.88
- 2021: 1.49
- 2020: 1.94
The recent rise in Fermenta Biotech Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What Fermenta Biotech Ltd Price to Sales Ratio Indicates for Investors
The Fermenta Biotech Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Fermenta Biotech Ltd Price to Sales Ratio Analysis Summary
The Fermenta Biotech Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Fermenta Biotech Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Fermenta Biotech Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.